Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1111-1120 of 1,220) with videos related to

Pageof 122
Sort By:
Hepatology (Baltimore, Md.)|July 2, 2010
Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNAZong-Gen Peng, Bo Fan, Na-Na Du, et al.
Frontiers in Public Health|July 1, 2026
Associations between body composition and physical performance in Chinese male adults: a cross-sectional studyHong-Mei Chen, Meng-Yuan Shu, Xiu-Chang Zhang, et al.
Nucleic Acids Research|November 16, 2017
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeuticsYing Hong Li, Chun Yan Yu, Xiao Xu Li, et al.
Gut Microbes|June 10, 2020
Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specificallyJunli Ma, Ying Hong, Ningning Zheng, et al.
British Journal of Cancer|May 8, 2020
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resectionWei-Ren Liu, Meng-Xin Tian, Zheng Tang, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesisYu-Fu Zhou, Shu-Shu Song, Meng-Xin Tian, et al.
Metabolic Brain Disease|October 19, 2021
The role of carbonic anhydrase III and autophagy in type 2 diabetes with cardio-cerebrovascular diseaseXiao-Ming Zhang, Ying-Hong Tao, Xiu-Ling Zhou, et al.
Clinical Pharmacology and Therapeutics|December 3, 2020
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry PerspectiveTycho Heimbach, Yuan Chen, Jun Chen, et al.
Plos One|March 20, 2012
Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resectionXiao-Yong Huang, Guo-Ming Shi, Ranjan Prasad Devbhandari, et al.
Frontiers in Oncology|September 5, 2022
Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learningWei-Feng Qu, Meng-Xin Tian, Jing-Tao Qiu, et al.
Pageof 122

Showing results (1111-1120 of 1,220) with videos related to

Sort By:
Pageof 122
Hepatology (Baltimore, Md.)|July 2, 2010
Small molecular compounds that inhibit hepatitis C virus replication through destabilizing heat shock cognate 70 messenger RNAZong-Gen Peng, Bo Fan, Na-Na Du, et al.
Frontiers in Public Health|July 1, 2026
Associations between body composition and physical performance in Chinese male adults: a cross-sectional studyHong-Mei Chen, Meng-Yuan Shu, Xiu-Chang Zhang, et al.
Nucleic Acids Research|November 16, 2017
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeuticsYing Hong Li, Chun Yan Yu, Xiao Xu Li, et al.
Gut Microbes|June 10, 2020
Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specificallyJunli Ma, Ying Hong, Ningning Zheng, et al.
British Journal of Cancer|May 8, 2020
Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resectionWei-Ren Liu, Meng-Xin Tian, Zheng Tang, et al.
Journal for Immunotherapy of Cancer|August 20, 2021
Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesisYu-Fu Zhou, Shu-Shu Song, Meng-Xin Tian, et al.
Metabolic Brain Disease|October 19, 2021
The role of carbonic anhydrase III and autophagy in type 2 diabetes with cardio-cerebrovascular diseaseXiao-Ming Zhang, Ying-Hong Tao, Xiu-Ling Zhou, et al.
Clinical Pharmacology and Therapeutics|December 3, 2020
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry PerspectiveTycho Heimbach, Yuan Chen, Jun Chen, et al.
Plos One|March 20, 2012
Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resectionXiao-Yong Huang, Guo-Ming Shi, Ranjan Prasad Devbhandari, et al.
Frontiers in Oncology|September 5, 2022
Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learningWei-Feng Qu, Meng-Xin Tian, Jing-Tao Qiu, et al.
Pageof 122